MedroxyPROGESTERone/Lidocaine Multi-Dose Vial recalled over sterility concerns

Recall date

September 12, 2015

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Official notice title

US Compounding Inc recalls MedroxyPROGESTERone/Lidocaine (150 mg/mL/1%) 10 mL Multi-Dose Vial, For IM Injection Only, Rx only, Compounded by US Co…

Recall number

D-0263-2016

FDA classification

Class II

Brand / firm

US Compounding Inc

Sold / distributed

Nationwide

Why it was recalled

Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

MedroxyPROGESTERone/Lidocaine (150 mg/mL/1%) 10 mL Multi-Dose Vial, For IM Injection Only, Rx only, Compounded by US Compounding Pharmacy, Conway, Arkansas, 72032, NDC 62295-3113-07